
|Articles|May 1, 2004
- Volume 0 0
Hair Dye Points to Cancer
Advertisement
Non?Hodgkins lymphoma (NHL) is more prevalent among women who began using hair dye prior to 1980, according to Yale researchers. Their study, reported recently in the American Journal of Epidemiology, found that women who used darker, permanent hair-coloring products for >25 years had the greatest risk. The researchers, however, did not find an increased risk of NHL among women who started using hair-coloring products in 1980 or later.
Articles in this issue
about 22 years ago
Aging Brings Changesabout 22 years ago
RxPRODUCT NEWS PROFILE: Cubicinabout 22 years ago
Can You Read These Rxs?about 22 years ago
Treatment of Sexually Transmitted Diseasesabout 22 years ago
Pharmacist Misappropriates Trade Secretsabout 22 years ago
Topiramate May Reduce Frequency and Severity of Migraine Headachesabout 22 years ago
HRT Is Linked to Breast Cancer Relapseabout 22 years ago
Early Treatment with Rasagiline May Slow Parkinson's Disease Impairmentabout 22 years ago
Psoriasis May Be Treated Safely and Effectively with AdalimumabAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































